Page last updated: 2024-08-18

acrolein and Hematologic Malignancies

acrolein has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chai, Y; Dai, M; Fan, Z; Huang, F; Huang, H; Jiang, Q; Li, X; Liu, Q; Lu, Y; Mai, Q; Meng, F; Shen, K; Sun, J; Wei, Q; Xu, D; Xu, N; Yu, G; Zhang, Y; Zhao, H; Zhou, D; Zhou, H; Zhou, Y	1

Trials

1 trial(s) available for acrolein and Hematologic Malignancies

Article	Year
Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine. Bone marrow transplantation, 2015, Volume: 50, Issue:11 Topics: Acrolein; Adolescent; Adult; Aged; Allografts; Biotransformation; Child; Cyclophosphamide; Cystitis; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hemorrhage; Histocompatibility; Humans; Incidence; Infusions, Intravenous; Mesna; Middle Aged; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Young Adult	2015

Article

Year

Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine.

Bone marrow transplantation, 2015, Volume: 50, Issue:11

Topics: Acrolein; Adolescent; Adult; Aged; Allografts; Biotransformation; Child; Cyclophosphamide; Cystitis; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hemorrhage; Histocompatibility; Humans; Incidence; Infusions, Intravenous; Mesna; Middle Aged; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Young Adult

2015